CN103948623B - A kind of bone surgery anti powder spray and preparation method thereof - Google Patents

A kind of bone surgery anti powder spray and preparation method thereof Download PDF

Info

Publication number
CN103948623B
CN103948623B CN201410185092.5A CN201410185092A CN103948623B CN 103948623 B CN103948623 B CN 103948623B CN 201410185092 A CN201410185092 A CN 201410185092A CN 103948623 B CN103948623 B CN 103948623B
Authority
CN
China
Prior art keywords
powder spray
bone surgery
hyaluronate sodium
fine powder
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410185092.5A
Other languages
Chinese (zh)
Other versions
CN103948623A (en
Inventor
纪翔
苏世先
胡全君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Chengyang Peoples Hospital
Original Assignee
Qingdao Chengyang Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Chengyang Peoples Hospital filed Critical Qingdao Chengyang Peoples Hospital
Priority to CN201410185092.5A priority Critical patent/CN103948623B/en
Publication of CN103948623A publication Critical patent/CN103948623A/en
Application granted granted Critical
Publication of CN103948623B publication Critical patent/CN103948623B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to field of medicaments, it is specifically related to a kind of bone surgery anti powder spray and preparation method thereof, it is made up of hyaluronate sodium, chitin derivativ and anti-inflammatory analgesic agent, wherein, the mass ratio of hyaluronate sodium, chitin derivativ and anti-inflammatory analgesic agent three is 1:0.3~1:0.01~0.1.During preparation, hyaluronate sodium, chitin derivativ and anti-inflammatory analgesic agent are weighed mixing by above-mentioned formula, is then ground to fine powder, fine powder is crossed 200 mesh sieves, after fine powder packaging of aluminium foil bag after sieving, ethane via epoxyethane or microwave are degerming, obtain bone surgery anti powder spray.It is an advantage of the current invention that: cooperate between each composition of medicine, and make powder spray use, in terms of adhesion between prevention of postoperative joint tissue, wound healing and easing pain and diminishing inflammation, there is obvious action, and steady quality, low cost, easy to use, good with the adhesiveness of tissue, meet Clinical practice requirement.

Description

A kind of bone surgery anti powder spray and preparation method thereof
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of bone surgery anti powder spray and preparation side thereof Method.
Background technology
Joint accretion refers to periarticular skin, muscle, tendon, and nervus vasculairs etc. change and cause The dyskinesia.Having loose composition and fine and close composition in the tissue of human body, the former constitutes joint capsule, muscle knot Charge-coupled tissue layer, subcutaneous tissue etc., be all the most movable part, the upper collagen fiber of histology and fine-structure mesh fiber Do not have netted, do not possess certain structure.In contrast, fine and close conjunctive tissue, as sarolemma, aponeurosis (aponeuroses) etc. Composition densification network structure.The cicatrix formed after wound is exactly this tissue.The treatment of orthopaedics articular trauma Cheng Zhong, if keeping the motion at this, then loose conjunctive tissue is maintained existing, if contrary therapeutic process Middle limitation of movement, then fine and close conjunctive tissue propagation, the mobility at impaired place is significantly restricted, and this is viscous after wound Mechanism even.In addition the splicing mechanism caused by the inertia of adhesion the most modal joint also with this Identical, owing to lacking motion, blood circulation slows down open texture cripetura, follows the string, slides and extensibility And form compact tissue.Such process occurs at joint capsule, sarolemma, muscle conjunctive tissue, ligament etc., And cause joint motion limited.Even normal arthrodesis is if 4 weeks, also can produce considerable degree of Adhesion.
Bone surgery occurs joint accretion is common following three kinds of reasons: the posterior joint adhesion of (1) wound, as Knee ligament, meniscus injury etc.;(2) Ineffective internal fixation, after plaster fixing, after fixation with small splint. (3) the useless property used joint accretion, joint of lumbar vertebra adhesion as caused by long-term bed, hip joint adhesion, knee joint is glued Even.
Summary of the invention
According to above the deficiencies in the prior art, the present invention provide a kind of bone surgery anti powder spray and Preparation method, is used for preventing around arthroscopy, nervous tissue, after the bone surgery such as tendon repair Tissue adhesion, has internal retention time long, preventing adhesiving effect obvious action.
A kind of bone surgery anti powder spray of the present invention, is derived by hyaluronate sodium, chitin Thing and anti-inflammatory analgesic agent composition, wherein, hyaluronate sodium, chitin derivativ and anti-inflammatory analgesic agent three's Mass ratio is 1:0.3~1:0.01~0.1.
Wherein, described chitin derivativ is preferably carboxymethyl chitin, Chitofilmer or succinyl One in chitin.
Anti-inflammatory analgesic agent is preferably in diphenhydramine, amitriptyline, Ketanserine, ibuprofen or indomethacin A kind of.
The preparation method of a kind of bone surgery anti powder spray, by hyaluronate sodium, chitin derivativ Weigh mixing with anti-inflammatory analgesic agent by above-mentioned formula, be then ground to fine powder, fine powder is crossed 200 mesh sieves, mistake After fine powder packaging of aluminium foil bag after sieve, ethane via epoxyethane or microwave are degerming, obtain bone surgery anti powder Mist agent.
Hyaluronate sodium is a kind of linear polyanionic polysaccharide, and as material necessary to Human Physiology, it is wide In the general various tissues being present in animal, including connective tissue, skin, cartilage, vitreum and synovial fluid etc.. Hyaluronate sodium molecular weight is up to 4 million to five megadaltons, in aqueous, with random spiral type Formula exists, and has the biggest molecule volume, can be woven and penetrate mutually at low concentrations so that it is have Specific rheological properties.Hyaluronate sodium prevents the mechanism of postoperative ankle tissue adhesion to be summarized as: (1) Form polymolecular network structure after dissolving, injured tissue is separated with normal serous coat, play space obstacle and make With and lubrication, reduce friction;(2) suppress hemorrhage and ooze out, reducing and can form permanent adhesion skeleton Clot quantity, suppression albumen is calm;(3) suppression post-operation inflammatory cell migration and phagocytosis, suppression blood is little The deposition of plate, promotes wound healing;(4) stimulate growth and the differentiation of serous coat cell, make wound serous coat reach Physiological is repaired.Additionally, hyaluronate sodium powder spray to be better than hyaluronate sodium in terms of preventing tissue adhesion molten Liquid and gel, sodium hyaluronate solution and gel are low due to concentration, and molecular weight is little, are inhaled the most soon Incorporate solution, weaken its iris action at tissue surface, and hyaluronate sodium powder spray is sprayed on organization table Behind face, having a progressively course of dissolution, be partially formed high concentration gel simultaneously, local visco-elasticity is high and internal Retention time is long, forms effective barrier, so its preventing adhesiving effect is notable in the serous coat reparation phase.
Chitin derivativ is a kind of chitosan, the present invention select carboxymethyl chitin, Chitofilmer or One in succinyl chitin.Chitin derivativ has good affinity, antigenicity to human body cell Low, safety is high, at personal injury position energy activating cell, produces collagen fiber in a large number, and collagen fiber can Quickly form careful skin, will not leave behind cicatrix, at treatment burn, scald, wound, acceleration wound more Conjunction, hemostasis, antiinflammatory aspect special effect.The powder spray that chitin derivativ is made glues at prevention of postoperative tissue Even, wound healing and ease pain have obvious action.
Hyaluronate sodium is combined by the present invention with chitin derivativ, then is equipped with anti-inflammatory analgesic agent, inventor Through lot of experiments, determine three's proportion relation, thus reach to prevent the maximization of adhesion effect.
It is an advantage of the current invention that: cooperate between each composition of medicine, and make powder spray use, Adhesion between prevention of postoperative joint tissue, wound healing and easing pain and diminishing inflammation aspect have obvious action, and Steady quality, low cost, easy to use, good with the adhesiveness of tissue, meet Clinical practice requirement.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1:
A kind of bone surgery anti powder spray, by hyaluronate sodium, carboxymethyl chitin and diphenhydramine Composition, the mass ratio of three is 1:1:0.1.
Embodiment 2:
A kind of bone surgery anti powder spray, by hyaluronate sodium, Chitofilmer and amitriptyline Composition, the mass ratio of three is 1:0.5:0.05.
Embodiment 3:
A kind of bone surgery anti powder spray, by hyaluronate sodium, succinyl chitin and ibuprofen group Becoming, the mass ratio of three is 1:0.3:0.02.
Embodiment 1~3 is prepared according to following preparation method, by hyaluronate sodium, chitin derivativ and antiinflammatory Analgesic weighs mixing by above-mentioned formula, is then ground to fine powder, and fine powder is crossed 200 mesh sieves, thin after sieving After powder packaging of aluminium foil bag, ethane via epoxyethane or microwave are degerming, obtain bone surgery anti powder spray.

Claims (1)

1. a bone surgery anti powder spray, it is characterised in that be made up of hyaluronate sodium, carboxymethyl chitin and diphenhydramine, wherein, The mass ratio of hyaluronate sodium, carboxymethyl chitin and diphenhydramine composition is 1:1:0.1;
The preparation method of described bone surgery anti powder spray is: by hyaluronate sodium, carboxymethyl chitin and diphenhydramine by above-mentioned formula Weigh mixing, be then ground to fine powder, fine powder is crossed 200 mesh sieves, fine powder packaging of aluminium foil bag after sieving, ethane via epoxyethane or microwave degerming after, Obtain bone surgery anti powder spray.
CN201410185092.5A 2014-05-04 2014-05-04 A kind of bone surgery anti powder spray and preparation method thereof Expired - Fee Related CN103948623B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410185092.5A CN103948623B (en) 2014-05-04 2014-05-04 A kind of bone surgery anti powder spray and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410185092.5A CN103948623B (en) 2014-05-04 2014-05-04 A kind of bone surgery anti powder spray and preparation method thereof

Publications (2)

Publication Number Publication Date
CN103948623A CN103948623A (en) 2014-07-30
CN103948623B true CN103948623B (en) 2016-08-31

Family

ID=51326065

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410185092.5A Expired - Fee Related CN103948623B (en) 2014-05-04 2014-05-04 A kind of bone surgery anti powder spray and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103948623B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1239657A (en) * 1998-06-24 1999-12-29 凌沛学 Antisticking particle and powder containing sodium hyaluronate and their preparation process
CN103285030A (en) * 2012-02-28 2013-09-11 凌沛学 Xanthan gum-containing anti-blocking preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100386090C (en) * 2006-07-08 2008-05-07 青岛博益特生物材料有限公司 Medical dust cloud agent or granular agent and its use
KR101062068B1 (en) * 2008-12-01 2011-09-02 포항공과대학교 산학협력단 Anti-adhesion Composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1239657A (en) * 1998-06-24 1999-12-29 凌沛学 Antisticking particle and powder containing sodium hyaluronate and their preparation process
CN103285030A (en) * 2012-02-28 2013-09-11 凌沛学 Xanthan gum-containing anti-blocking preparation

Also Published As

Publication number Publication date
CN103948623A (en) 2014-07-30

Similar Documents

Publication Publication Date Title
JP6686195B2 (en) Hydrogel membrane for adhesion prevention
JP6868314B2 (en) Wound dressing containing hyaluronic acid-calcium and polylysine and its manufacturing method
US20060110459A1 (en) Triple natural polymer viscoelastic composition
BR112018009306B1 (en) COMPOSITION OF FIBERS AND/OR HEMOSTATIC AGGREGATE BASED ON CELLULOSE, METHOD OF MANUFACTURING, GEL, AND METHOD FOR FORMATION OF A GEL
Dowling et al. Determination of efficacy of a novel alginate dressing in a lethal arterial injury model in swine
JP2016533775A (en) Chitosan paste wound dressing
Wang et al. Intra-articular injection of hyaluronic acid for the reduction in joint adhesion formation in a rabbit model of knee injury
JP5636225B2 (en) Pharmaceutical composition for use in the treatment and prevention of inflammatory bowel disease (IBD)
Zhang et al. A self-healing hydrogel wound dressing based on oxidized Bletilla striata polysaccharide and cationic gelatin for skin trauma treatment
CN104906029A (en) Nasal cavity preparation and preparing method and application thereof
CN103948623B (en) A kind of bone surgery anti powder spray and preparation method thereof
EP3131521A2 (en) Composition for improving the appearance of ageing skin
CN104027850A (en) Postoperative washing agent and preparation method thereof
CN103961366A (en) Anti-adhesion dry powder inhalation for orthopedics department post operation, and preparation of anti-adhesion dry powder inhalation
CN103948929A (en) Anti-adhesion powder inhalation applied to orthopedic operation and preparation method of anti-adhesion powder inhalation
CN103961710A (en) Anti-adhesion dry powder inhalation for orthopedics department postoperative joint tissues, and preparation of anti-adhesion dry powder inhalation
CN103961708A (en) Anti-adhesion dry powder inhaler used after orthopedic surgeries and preparing method thereof
CN102302603A (en) External medicament for treating traumatic injury
US20190269820A1 (en) Biological adhesives and sealants and methods of using the same
CN109568635B (en) In-situ expansion high-water-absorption hemostatic material and preparation method thereof
CN105963430B (en) Chinese medicine composition and its preparation method and application
US10052408B2 (en) Compositions of carboxypolysaccharides and polyalkylene oxides cross-linked using polyhydroxyl organic anions
CN104622890B (en) Product for preventing post-operative adherence, as well as preparation method and application thereof
CN112972387A (en) Lyotropic liquid crystal precursor and preparation method and application thereof
TR2022015122A2 (en) IN-SITU GEL FORMULATION CONTAINING HYALURONIC ACID AND CETHYL MYRISTOLATE AND THE USE OF THIS FORMULATION IN OSTEOARTHRITIS TREATMENT

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160831

Termination date: 20170504